New hope for advanced stomach cancer: drug cocktails under trial

NCT ID NCT05329766

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether combining new drugs with or without chemotherapy can safely control advanced stomach, GEJ, or esophageal cancer. About 332 adults with inoperable or metastatic disease will receive different treatment combinations. The goal is to find more effective options that shrink tumors and extend life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Adenocarcinoma Of Esophagus digestive system cancer esophageal adenocarcinoma gastric adenocarcinoma gastric neoplasm gastroesophageal junction adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    Phoenix, Arizona, 85054, United States

  • Research Site

    Los Angeles, California, 90033, United States

  • Research Site

    Santa Monica, California, 90024, United States

  • Research Site

    Derby, Connecticut, 06418, United States

  • Research Site

    Fort Myers, Florida, 33901, United States

  • Research Site

    Jacksonville, Florida, 32224, United States

  • Research Site

    St. Petersburg, Florida, 33705, United States

  • Research Site

    Boston, Massachusetts, 02109, United States

  • Research Site

    New York, New York, 10021-0005, United States

  • Research Site

    New York, New York, 10032, United States

  • Research Site

    Durham, North Carolina, 27710, United States

  • Research Site

    Columbus, Ohio, 43219, United States

  • Research Site

    Oklahoma City, Oklahoma, 73104, United States

  • Research Site

    Portland, Oregon, 97213, United States

  • Research Site

    Nashville, Tennessee, 37203, United States

  • Research Site

    Nashville, Tennessee, 37232, United States

  • Research Site

    Fairfax, Virginia, 22031, United States

  • Research Site

    Toronto, Canada

  • Research Site

    Las Condes, Chile

  • Research Site

    Recoleta, Chile

  • Research Site

    Santiago, Chile

  • Research Site

    Talca, Chile

  • Research Site

    Bordeaux, France

  • Research Site

    Brest, France

  • Research Site

    Caen, France

  • Research Site

    Lille, France

  • Research Site

    Lyon, France

  • Research Site

    Marseille, France

  • Research Site

    Montpellier, France

  • Research Site

    Plérin, France

  • Research Site

    Poitiers, France

  • Research Site

    Rouen, France

  • Research Site

    Toulouse, France

  • Research Site

    Villejuif, France

  • Research Site

    Belgrade, Serbia

  • Research Site

    Kamenitz, Serbia

  • Research Site

    Kragujevac, Serbia

  • Research Site

    Busan, South Korea

  • Research Site

    Daegu, South Korea

  • Research Site

    Hwasun, South Korea

  • Research Site

    Seongnam-si, South Korea

  • Research Site

    Seoul, South Korea

  • Research Site

    Suwon, South Korea